134 related articles for article (PubMed ID: 32351853)
1. Multi-focal Lytic Lesions in a Patient with Myelofibrosis: A Case Report.
Burnham RR; Johnson B; Lomasney LM; Borys D; Cooper AR
Cureus; 2020 Mar; 12(3):e7475. PubMed ID: 32351853
[TBL] [Abstract][Full Text] [Related]
2. Singular case of osteolytic lesions revealing transformation of myeloproliferative syndrome to acute leukemia.
Guillaume D; Hélène M; Béatrice B
Joint Bone Spine; 2019 Mar; 86(2):251-253. PubMed ID: 30471421
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
4. Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.
Dührsen U; Uppenkamp M; Meusers P; König E; Brittinger G
Blut; 1988 Mar; 56(3):97-102. PubMed ID: 3355902
[TBL] [Abstract][Full Text] [Related]
5. A review of myelofibrosis in dogs.
Reagan WJ
Toxicol Pathol; 1993; 21(2):164-9. PubMed ID: 8210938
[TBL] [Abstract][Full Text] [Related]
6. Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation.
Stein BL; Moliterno AR
JAMA; 2010 Jun; 303(24):2513-8. PubMed ID: 20571018
[TBL] [Abstract][Full Text] [Related]
7. Acute myelofibrosis in progressive systemic sclerosis. Report of a case developing during long term chlorambucil therapy and discussion of pathogenetic factors.
Gisser SD; Chung KB
Am J Med; 1979 Jul; 67(1):151-4. PubMed ID: 463908
[TBL] [Abstract][Full Text] [Related]
8. Diffuse purely osteolytic lesions in myelofibrosis.
Kosmidis PA; Palacas CG; Axelrod AR
Cancer; 1980 Nov; 46(10):2263-5. PubMed ID: 7427866
[TBL] [Abstract][Full Text] [Related]
9. Agnogenic myelofibrosis in children--a case report and review of the literature.
Hamazaki M; Mugishima H
Acta Pathol Jpn; 1981 Jan; 31(1):143-52. PubMed ID: 7234418
[TBL] [Abstract][Full Text] [Related]
10. Elevated TNF-alpha and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis.
Jurisic V; Terzic T; Pavlovic S; Colovic N; Colovic M
Pathol Res Pract; 2008; 204(2):129-32. PubMed ID: 17976926
[TBL] [Abstract][Full Text] [Related]
11. Generalized lymphadenopathy secondary to isolated extramedullary hematopoiesis as an initial manifestation of primary myelofibrosis.
Aljabry MS; Asiri S; Elsafi T; Elyamany G
Hematol Rep; 2018 May; 10(2):7588. PubMed ID: 30046414
[TBL] [Abstract][Full Text] [Related]
12. Properties of myelofibrosis-derived fibroblasts.
Castro-Malaspina H; Jhanwar SC
Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
[TBL] [Abstract][Full Text] [Related]
13. JAK2-positive cutaneous myelofibrosis presenting as sclerosing extramedullary hematopoietic tumors on the scalp: case presentation and review of the literature.
LeBlanc RE; Lester L; Kwong B; Rieger KE
J Cutan Pathol; 2015 Nov; 42(11):858-62. PubMed ID: 26153565
[TBL] [Abstract][Full Text] [Related]
14. Osteolytic bone lesions in a patient with idiopathic myelofibrosis and bronchial carcinoma.
Clutterbuck DJ; Morrison AE; Ludlam CA
J Clin Pathol; 1995 Sep; 48(9):867-8. PubMed ID: 7490324
[TBL] [Abstract][Full Text] [Related]
15. Sclerotic lesions of bone in myeloma.
Langley GR; Sabean HB; Sorger K
Can Med Assoc J; 1966 Apr; 94(18):940-6. PubMed ID: 4952377
[TBL] [Abstract][Full Text] [Related]
16. Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma.
Jung SH; Yang DH; Ahn JS; Kim YK; Kim HJ; Lee JJ
J Clin Apher; 2014 Dec; 29(6):305-10. PubMed ID: 24764270
[TBL] [Abstract][Full Text] [Related]
17. A basic classification and a comprehensive examination of pediatric myeloproliferative syndromes.
Gassas A; Doyle JJ; Weitzman S; Freedman MH; Hitzler JK; Sharathkumar A; Dror Y
J Pediatr Hematol Oncol; 2005 Apr; 27(4):192-6. PubMed ID: 15838389
[TBL] [Abstract][Full Text] [Related]
18. Unusual manifestations of hypereosinophilia.
Winkler CF; Snider HL; Yam LT
South Med J; 1981 Nov; 74(11):1401-3. PubMed ID: 7302642
[TBL] [Abstract][Full Text] [Related]
19. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
Nockowski P; Woźniak Z; Reich A; Maj J
Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
[TBL] [Abstract][Full Text] [Related]
20. Paediatrics primary myelofibrosis and acute stroke: A rare presentation.
Mazher W; Rizvi AH; Adam AM; Ali Mallick MS; Godil A
J Pak Med Assoc; 2017 Apr; 67(4):634-636. PubMed ID: 28420931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
